Accredited Investors’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$219K Sell
3,053
-420
-12% -$39.5K 0.01% 283
2026
Q1
$411K Sell
3,473
-197
-5% -$24.4K 0.02% 175
2025
Q4
$462K Buy
3,670
+18
+0.5% +$2.35K 0.02% 165
2025
Q3
$534K Sell
3,652
-466
-11% -$70.4K 0.03% 145
2025
Q2
$642K Buy
4,118
+1,074
+35% +$170K 0.04% 125
2025
Q1
$501K Buy
3,044
+21
+0.7% +$3.49K 0.03% 127
2024
Q4
$493K Buy
3,023
+28
+0.9% +$5.01K 0.03% 132
2024
Q3
$585K Hold
2,995
0.03% 122
2024
Q2
$519K Buy
2,995
+1
+0% +$166 0.03% 120
2024
Q1
$507K Hold
2,994
0.03% 127
2023
Q4
$591K Hold
2,994
0.04% 110
2023
Q3
$521K Hold
2,994
0.04% 108
2023
Q2
$516K Hold
2,994
0.04% 113
2023
Q1
$498K Hold
2,994
0.04% 109
2022
Q4
$439K Sell
2,994
-3
-0.1% -$444 0.04% 114
2022
Q3
$444K Buy
2,997
+4
+0.1% +$669 0.05% 102
2022
Q2
$514K Sell
2,993
-8
-0.3% -$1.38K 0.06% 101
2022
Q1
$566K Sell
3,001
-5
-0.2% -$988 0.05% 103
2021
Q4
$734K Buy
3,006
+13
+0.4% +$2.85K 0.07% 93
2021
Q3
$581K Hold
2,993
0.06% 94
2021
Q2
$558K Hold
2,993
0.06% 99
2021
Q1
$471K Buy
2,993
+1
+0% +$158 0.06% 100
2020
Q4
$495K Sell
2,992
-45
-1% -$7.32K 0.08% 91
2020
Q3
$502K Sell
3,037
-21
-0.7% -$3.23K 0.11% 84
2020
Q2
$419K Sell
3,058
-250
-8% -$32.6K 0.09% 90
2020
Q1
$389K Hold
3,308
0.09% 93
2019
Q4
$438K Hold
3,308
0.07% 93
2019
Q3
$412K Buy
3,308
+45
+1% +$5.43K 0.08% 88
2019
Q2
$370K Sell
3,263
-300
-8% -$31.4K 0.07% 96
2019
Q1
$359K Buy
+3,563
New +$324K 0.07% 93

Other funds holding ZTS

Accredited Investors's ZTS Position: Q2 2026 in Review

Accredited Investors reduced its Zoetis (ZTS) stake by 12% in Q2 2026, selling an estimated $39.5K and leaving 3,053 shares worth $219K. The position accounts for 0.01% of the portfolio, ranked #283.

Accredited Investors first reported a position in ZTS in Q1 2019 and has held it in 30 quarters since. The position peaked at $734K in Q4 2021. 274 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • Accredited Investors held 3,053 shares of Zoetis worth $219K as of Q2 2026.
  • Accredited Investors sold 420 Zoetis shares in Q2 2026, an estimated $39.5K.
  • Zoetis made up 0.01% of Accredited Investors's portfolio in Q2 2026, its #283 holding.
  • Accredited Investors first reported a position in Zoetis in Q1 2019 and has held it in 30 quarters since.
  • Accredited Investors's Zoetis position peaked at $734K in Q4 2021.
  • 274 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Accredited Investors's 13F filing for Q2 2026, filed 21 Jul 2026.